We have already suggested two possible factors determining the clinical severity of SMA: one is complex formation with partner proteins bound to the mutated SMN1 protein [20] and the other is stability of the mutated SMN1 protein [22]. Here, SMN1 is linked to proximal spinal muscular atrophy.